Research - Health Care - Harvard Business School

September 8, 2020
Article

Allocation of COVID-19 Relief Funding to Disproportionately Black Counties

By: Pragya Kakani, Amitabh Chandra and Sendhil Mullainathan

This study describes correlations between the dollar amount of relief funding authorized by the US Congress to fund prevention, diagnosis, and treatment of coronavirus disease 2019 (COVID-19) and to reimburse health care entities for lost revenues, and county-level...

September 17, 2020
Article

How to Protect Vulnerable Older Patients during the Pandemic: Lessons from Innovative Primary Care Organizations That Serve These High-Risk Patients

By: Umar Ikram, Susanna Gallani, Jose F. Figueroa and Thomas W. Feeley

Older people (70 years and older) with multiple chronic conditions have the highest risk of being hospitalized and dying from COVID-19. The recent COVID-19 pandemic has highlighted how a strong primary care system can play an important role in protecting this group of...

September–October 2020
Article

The Past, Present, and (Near) Future of Gene Therapy and Gene Editing

By: Julia Pian, Amitabh Chandra and Ariel Dora Stern

Emerging gene therapy and gene-editing technologies will have a growing impact on patient lives and health-care delivery. We analyzed a decade of data on clinical trials and venture capital investments to understand the likely trajectory of genetically focused...

August 2020
Case

1928 Diagnostics: Fighting Antibiotics Resistance

By: Ariel D. Stern and Daniela Beyersdorfer

In 2019, the co-founders of the Swedish medical start-up 1928 Diagnostics, CEO Dr. Kristina Lagerstedt and COO Dr. Susanne Staaf, had to pick the right business model to commercialize their novel technology to hospitals and health care providers. Developed in...

Forthcoming
Article

A Mixed Methods Study of Change Processes Enabling Effective Transition to Team-based Care

By: Michael Anne Kyle, Emma-Louise Aveling and Sara J. Singer

Team-based care is considered central to achieving value in primary care, yet results of large-scale primary care transformation initiatives have been mixed. We explore how underlying change processes influence the effectiveness of transition to team-based care. We...

Forthcoming
Article

How Has Covid-19 Affected Health Insurance Offered by Small Businesses in the U.S.? Early Evidence from a Survey

By: Leemore S. Dafny, Yin Wei Soon, Zoë Cullen and Christopher T. Stanton

As the COVID-19 pandemic stretches toward its third quarter, loss of health insurance coverage has not figured prominently in the public debate. Data in this report demonstrate why that is, but also suggest that the apparent stability is fragile, with potentially...

20 Aug 2020
Working Paper Summaries

Can Shared Service Delivery Increase Customer Engagement? A Study of Shared Medical Appointments

by Ryan W. Buell, Kamalini Ramdas, and Nazlı Sönmez

                                       Shared service delivery means that customers are served in groups rather than individually. Results from a large-scale study of glaucoma follow-up appointments at a major eye hospital indicate that shared service delivery can significantly improve patients’ verbal and...

20 Aug 2020
News

The U.S. Needs an SEC for its Health Care System

By: Regina Herzlinger

                                       The U.S. health care system suffers from a lack of transparency. Employers, insurers and individual consumers pay varying prices for treatments, drugs and digital information of varying quality, without knowing whether the prices are relatively high or low, or whether...

Forthcoming
Article

Value of New Performance Information in Healthcare: Evidence from Japan

By: Susanna Gallani, Takehisa Kajiwara and Ranjani Krishnan

Mandatory measurement and disclosure of outcome measures are commonly used policy tools in healthcare. The effectiveness of such disclosures relies on the extent to which the new information produced by the mandatory system is internalized by the healthcare...

August 2020
Article

A History of Prescription Drug Monitoring Programs in the United States: Political Appeal and Public Health Efficacy

By: A Jay Holmgren, Alyssa Botelho and Allan M Brandt

Prescription drug monitoring programs (PDMPs) have become a widely embraced policy to address the US opioid crisis. Despite mixed scientific evidence on their effectiveness at improving health and reducing overdose deaths, 49 states and Washington, DC have adopted...

23 Jul 2020
Research & Ideas

How Countries Use Financial Policy to Fight COVID-19

by Rachel Layne

                                       Developing countries have fewer fiscal tools and policy options to combat COVID-19 damage to their economies, according to research by Alberto Cavallo and colleagues.

23 Jul 2020
News

The Long Game of Coronavirus Research

Re: Tsedal Neeley

                                       Last month, Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases, spoke at a biotech conference, where he emphasized how much is still unknown about the coronavirus. “I thought H.I.V. was a complicated disease,” he said. “It’s really...

Faculty & Research

Making a Difference in Health Care